R203C and C382R mutations in FGFR2 were respectively harbored by two different patients (Fig. 2A), which have been reported in ICC and other tumor types likely oncogenic [15, 19–21]. This evidence concerns the gene FGFR2 and intrahepatic cholangiocarcinoma.